Pharmacokinetics and Bioavailability Study of Tubeimoside I in ICR Mice by UPLC-MS/MS

Figure 4

Mean blood concentration of TBMS-I after sublingual intravenous administration at the dose of 3 mg/kg and gavage of 15 mg/kg.